Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Aminopiperidine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel enzymatic route for R-3-aminopiperidine dihydrochloride offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101952252A details a tartaric acid resolution method for high-purity piperidine intermediates, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN101977899A details a cost-effective Pd-catalyzed hydrogenation and mandelic acid resolution for high-purity piperidine intermediates, ensuring supply chain stability.
Discover the cost-effective palladium-catalyzed manufacturing method for piperidine-3-ylcarbamate intermediates. Enhance supply chain reliability and reduce production costs for diabetes drug synthesis.
Novel chemo-enzymatic route for diabetes drug intermediate offers high purity and scalable manufacturing solutions for global pharmaceutical supply chains efficiently.
Patent CN1305849C reveals a cost-effective 3-step synthesis for 3-methylaminopiperidine, eliminating noble metal catalysts and significantly improving yield for pharmaceutical manufacturing.
Novel chiral induction route for (R)-3-aminopiperidine eliminates resolution waste. Delivers high ee value and cost reduction in API manufacturing for global supply chains.
Patent CN103373953A reveals a safe, high-yield route for 3-aminopiperidine, offering cost-effective API intermediate manufacturing solutions.
Novel chiral catalytic route for (R)-3-aminopiperidine. Higher yield, lower cost, scalable production for DPP-IV inhibitors. Reliable pharmaceutical intermediates supplier.
Patent CN121204184A reveals high-purity biocatalytic route. Enhanced scalability and cost efficiency for pharmaceutical manufacturing supply chains.
Patent CN114591219A details a water-based resolution process for S-3-aminopiperidine dihydrochloride, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103319399A details a green Hoffmann rearrangement route for R-3-aminopiperidine dihydrochloride, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel water-based resolution method for S-3-aminopiperidine. High purity 99.5% yield 72%. Cost-effective pharmaceutical intermediate supply chain solution.
Patent CN103113290A details a cost-effective Pd/C catalyzed route for 3-methylaminopiperidine, offering significant supply chain advantages for fluoroquinolone producers.
Advanced synthesis of 3-aminopiperidine-2,6-dione hydrochloride via L-glutamic acid cyclization. Offers superior purity, reduced toxicity, and cost-effective scaling for pharmaceutical supply chains.
Advanced preparation method for (R)-1-Boc-3-aminopiperidine via chiral resolution. Safe, scalable process for DPP-IV inhibitor intermediates with reduced costs.
Novel copper-catalyzed radical coupling method for chiral 3-aminopiperidine. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN104837817B introduces a safer water-based synthesis route for 3-amino-piperidine intermediates enabling cost reduction and reliable supply for pharmaceutical manufacturing.